Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-364
Closed -$14K 2027
2020
Q3
$14K Buy
+364
New +$16K ﹤0.01% 937
2020
Q1
Sell
-488
Closed -$20K 1330
2019
Q4
$20K Buy
+488
New +$20.5K ﹤0.01% 885
2019
Q3
Sell
-10
Closed 1317
2019
Q2
$0 Sell
10
-14
-58% -$591 ﹤0.01% 1384
2019
Q1
$1K Sell
24
-432
-95% -$22K ﹤0.01% 960
2018
Q4
$22K Buy
+456
New +$27.3K 0.01% 441

Other funds holding SRDX

Point72 Hong Kong's SRDX Position: Q4 2020 in Review

Point72 Hong Kong sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 364 shares — an estimated $14K sold.

Point72 Hong Kong first reported a position in SRDX in Q4 2018 and held it in 5 quarters. The position peaked at $22K in Q4 2018. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.

  • Point72 Hong Kong reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 364 Surmodics shares in Q4 2020, an estimated $14K.
  • Point72 Hong Kong first reported a position in Surmodics in Q4 2018 and held it in 5 quarters.
  • Point72 Hong Kong's Surmodics position peaked at $22K in Q4 2018.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.

Based on Point72 Hong Kong's 13F filing for Q4 2020, filed 16 Feb 2021.